Sinovac

China Promotes Third Shot of Sinovac Coronavirus Vaccine Product

China’s state-run Global Times on Tuesday quoted a “new study,” which has not yet been peer-reviewed, that suggested a third does of China’s ineffective Sinovac vaccine could produce a “remarkable increase in antibody levels” and a ‘strong boost in immune response,” bringing Sinovac closer to the quality of competing products such as AstraZeneca’s vaccine.

A medical worker prepares to administer a does of Covid-19 coronavirus vaccine at a community health center in Nantong, in eastern China's Jiangsu province on March 2, 2021. (Photo by STR / AFP) / China OUT (Photo by STR/AFP via Getty Images)

China’s Sinovac Urges Third Dose of Its Low-Quality Vaccine

Sinovac Biotech, a Chinese company responsible for the development of one of the least effective Chinese coronavirus vaccines currently in global circulation, suggested on Sunday that patients should receive a third “booster” dose of its product to improve its performance.

In this Sept. 24, 2020, file photo, a worker inspects syringes of a vaccine for COVID-19 produced by Sinovac at its factory in Beijing. China approved two new more COVID-19 vaccines for wider use Thursday, adding to its growing arsenal of shots: one from CanSino Biologics, and a second one …

After Chinese Vaccine Fails, China Launches Smear Campaign Against Pfizer

A few days after attempting to dismiss disappointing test results from Brazil on China’s Sinovac vaccine candidate for the Chinese coronavirus, Chinese state media turned to attacking Sinovac’s American competitors Pfizer and Moderna, calling for a worldwide ban on Pfizer’s vaccine after 23 elderly Norwegians died, ostensibly from reactions to the Pfizer shots.

Chinese health care workers and volunteers wear protective clothing as they register people to receive a COVID-19 vaccine jab at a mass vaccination center for Chaoyang District on January 15, 2021 in Beijing, China. With at least 5 homegrown vaccines nearing approval, China says it will vaccinate 50 million people …